Sandbox cvsd2: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
|||
| Line 7: | Line 7: | ||
'''''For patient information, click <u>[[XXXXX (patient information)|here]]'''''</u>. | '''''For patient information, click <u>[[XXXXX (patient information)|here]]'''''</u>. | ||
{{SB}} | {{SB}} | ||
==Overview== | ==Overview== | ||
<ref name="pmid24732918">{{cite journal| author=Hizoh I, Majoros Z, Major L, Gulyas Z, Szabo G, Kerecsen G et al.| title=Need for prophylactic application of verapamil in transradial coronary procedures: a randomized trial. The VITRIOL (is Verapamil In TransRadial Interventions OmittabLe?) trial. | journal=J Am Heart Assoc | year= 2014 | volume= 3 | issue= 2 | pages= e000588 | pmid=24732918 | doi=10.1161/JAHA.113.000588 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24732918 }} </ref> | |||
==Category== | ==Category== | ||
Revision as of 15:54, 21 August 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
For patient information, click here. Synonyms / Brand Names:
Overview
Category
FDA Package Insert
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
References
- ↑ Hizoh I, Majoros Z, Major L, Gulyas Z, Szabo G, Kerecsen G; et al. (2014). "Need for prophylactic application of verapamil in transradial coronary procedures: a randomized trial. The VITRIOL (is Verapamil In TransRadial Interventions OmittabLe?) trial". J Am Heart Assoc. 3 (2): e000588. doi:10.1161/JAHA.113.000588. PMID 24732918.